Form D · Biotechnology

Delphinus Medical Technologies, Inc.

Novi, MI · CIK 0001492534

Offering snapshot reported Apr 3, 2025 · SEC filing

Reported sold
$27.6M
Offering amount: $27.6M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 22, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$13.8M$27.6MApr 5, 2024: $5,279,445.00Apr 5, 2024Nov 26, 2024: $20,375,000.00Nov 26, 2024Apr 3, 2025: $27,602,177.00Apr 3, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,375,000 → $27,602,177

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 3, 2025Amendment$27,602,177$7,227,177vs Nov 26, 20248SEC filing
Nov 26, 2024Amendment$20,375,000$15,095,555vs Apr 5, 20248SEC filing
Apr 5, 2024Initial$5,279,445No comparison1SEC filing
Jun 30, 2023Initial$5,000,000No comparison9SEC filing
Sep 13, 2022Initial$30,406,961No comparison10SEC filing
Apr 20, 2017Initial$8,229,049No comparison9SEC filing
Sep 11, 2015Initial$39,547,131No comparison10SEC filing
Oct 12, 2010Amendment$7,162,500$1,162,500vs May 21, 20108SEC filing
May 21, 2010Initial$6,000,000No comparison6SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-509769

Source: Form D, filed Apr 3, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Elise Berman Executive
Hugo Braun Director
Rachel Brem Director
Francis Dobscha Executive
Neb Duric Executive
Neb Duric, Ph.D. Executive
Michael Emery Executive
Mark Forchette Director
Michael Fulton Director
William C. Greenway Director, Executive
Michael Gross Director
Ronald Ho Director
Robert P. Kelch Director
Paul Mc Creadie Director
John Neis Director
Shawn O'brien Executive
W. James Prowse Director, Executive
Heather Rone Executive
Olivier Roy Executive
Chris Sanders Executive
Debra Saunders Executive
Scott White Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
45525 Grand River Avenue
Novi, MI, 48374